Small-Molecule Inhibitors (SMIs) as an Effective Therapeutic Strategy for Endometrial Cancer

SIMPLE SUMMARY: Patients diagnosed with endometrial cancer (EC), the most common gynaecological malignancy in women worldwide, cope with a disease associated with poor prognosis and limited treatment options after first-line therapy when it reaches an advanced or metastatic stage. Lately, small-mole...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancers (Basel)
Autori principali: Megino-Luque, Cristina, Moiola, Cristian Pablo, Molins-Escuder, Clara, López-Gil, Carlos, Gil-Moreno, Antonio, Matias-Guiu, Xavier, Colas, Eva, Eritja, Núria
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2020
Soggetti:
Review
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7598629/
https://ncbi.nlm.nih.gov/pubmed/32987790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12102751
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi